New York [US], March 23 (ANI): Regeneron Pharmaceuticals Inc on Tuesday said that its dual antibody treatment for COVID-19 reduced symptomatic illness by four days at any level of dose tried in its clinical trial adding that the treatment also seemed to reduce hospitalizations and death by a
Washington [US], October 18 (ANI): The antibody levels in the blood of COVID-19 patients drop rapidly during the weeks after their bodies have cleared the virus and symptoms have subsided, suggest the findings of a new study.
Washington D.C. [USA], June 17 (ANI): Infectious disease experts are advocating for earlier actions to reduce hospitalizations and deaths from COVID-19.